ANI Pharmaceuticals Inc (ANIP)
66.14
+0.57
(+0.87%)
USD |
NASDAQ |
Apr 23, 16:00
66.14
0.00 (0.00%)
After-Hours: 18:31
ANI Pharmaceuticals Market Cap: 1.393B for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 1.381B |
| April 19, 2024 | 1.380B |
| April 18, 2024 | 1.361B |
| April 17, 2024 | 1.380B |
| April 16, 2024 | 1.381B |
| April 15, 2024 | 1.397B |
| April 12, 2024 | 1.409B |
| April 11, 2024 | 1.435B |
| April 10, 2024 | 1.411B |
| April 09, 2024 | 1.413B |
| April 08, 2024 | 1.424B |
| April 05, 2024 | 1.425B |
| April 04, 2024 | 1.431B |
| April 03, 2024 | 1.417B |
| April 02, 2024 | 1.406B |
| April 01, 2024 | 1.430B |
| March 28, 2024 | 1.456B |
| March 27, 2024 | 1.468B |
| March 26, 2024 | 1.465B |
| March 25, 2024 | 1.466B |
| March 22, 2024 | 1.466B |
| March 21, 2024 | 1.460B |
| March 20, 2024 | 1.436B |
| March 19, 2024 | 1.430B |
| March 18, 2024 | 1.425B |
| Date | Value |
|---|---|
| March 15, 2024 | 1.390B |
| March 14, 2024 | 1.392B |
| March 13, 2024 | 1.395B |
| March 12, 2024 | 1.402B |
| March 11, 2024 | 1.393B |
| March 08, 2024 | 1.420B |
| March 07, 2024 | 1.405B |
| March 06, 2024 | 1.386B |
| March 05, 2024 | 1.377B |
| March 04, 2024 | 1.399B |
| March 01, 2024 | 1.415B |
| February 29, 2024 | 1.426B |
| February 28, 2024 | 1.270B |
| February 27, 2024 | 1.263B |
| February 26, 2024 | 1.269B |
| February 23, 2024 | 1.246B |
| February 22, 2024 | 1.225B |
| February 21, 2024 | 1.180B |
| February 20, 2024 | 1.195B |
| February 16, 2024 | 1.222B |
| February 15, 2024 | 1.178B |
| February 14, 2024 | 1.148B |
| February 13, 2024 | 1.126B |
| February 12, 2024 | 1.167B |
| February 09, 2024 | 1.157B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
292.51M
Minimum
Nov 06 2020
1.468B
Maximum
Mar 27 2024
693.95M
Average
664.47M
Median
Market Cap Benchmarks
| Ligand Pharmaceuticals Inc | 1.239B |
| ADMA Biologics Inc | 1.491B |
| Dentsply Sirona Inc | 6.401B |
| Allogene Therapeutics Inc | 569.84M |
| Vanda Pharmaceuticals Inc | 266.11M |
Market Cap Related Metrics
| PE Ratio | 80.66 |
| PS Ratio | 2.473 |
| Price to Book Value | 3.220 |
| Price to Free Cash Flow | 11.99 |
| Price | 66.14 |
| Earnings Yield | 1.24% |
| Operating PE Ratio | 24.31 |
| Normalized PE Ratio | 72.22 |